WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Xi inspects Changsha in central China's Hunan ProvinceWang Yi reiterates Beijing's desire for peaceful reunification with TaiwanTop adviser reaffirms opposition to 'Taiwan independence'China's top legislature to hold closing meeting on MondaySpokesman calls on U.S. to translate commitment into actionIAEA chief meets Putin over nuclear safetyWang's NZ visit comes at pivotal time in relations, analysts sayPeaceful principles playing key role in intl relations, FM saysLegislators eye growth boostBeijing opposes Burns' definition of Sino
3.0397s , 6496.5703125 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Culture Craft news portal